Also trades as: BOT.AX (ASX) · $vol 0M
BXPHF OTC
Botanix Pharmaceuticals Limited
1W: +46.8%
1M: -4.8%
3M: +40.4%
YTD: -79.8%
1Y: -88.1%
3Y: -86.6%
5Y: -77.1%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$106M
-18.0% ▼
5Y CAGR: +37.0%
Total Liabilities
$42M
-11.3% ▼
5Y CAGR: +105.7%
Shareholders Equity
$63M
-22.0% ▼
5Y CAGR: +25.0%
Cash & Investments
$37M
-43.7% ▼
5Y CAGR: +11.2%
Total Debt
$15M
-54.2% ▼
5Y CAGR: +124.3%
Net Debt
-$22M
+33.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $7M | $10M | $79M | $65M | $37M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $7M | $10M | $79M | $65M | $37M |
| Net Receivables | $141K | $397K | $817K | $3M | $7M |
| Inventory | $3M | $3M | $1M | $28M | $31M |
| Other Current Assets | $0 | $92K | $1M | $0 | $6M |
| Total Current Assets | $11M | $14M | $83M | $100M | $80M |
| Property, Plant & Equip. | $179K | $65K | $72K | $1M | $815K |
| Goodwill & Intangibles | $3M | $11M | $29M | $28M | $25M |
| Long-Term Investments | $62K | $63K | $0 | $0 | $0 |
| Other Non-Current Assets | $62K | $63K | $0 | $0 | $0 |
| Total Non-Current Assets | $4M | $11M | $30M | $30M | $26M |
| Total Assets | $14M | $25M | $112M | $129M | $106M |
| — Liabilities — | |||||
| Accounts Payable | $5M | $1M | $3M | $9M | $6M |
| Short-Term Debt | $0 | $0 | $0 | $9M | $14M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $986K | $343K | $440K | $400K | $11M |
| Total Current Liabilities | $6M | $2M | $4M | $25M | $31M |
| Long-Term Debt | $0 | $0 | $0 | $22M | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $11M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $23M | $11M |
| Total Liabilities | $6M | $2M | $4M | $48M | $42M |
| — Equity — | |||||
| Common Stock | $71M | $93M | $188M | $226M | $0 |
| Retained Earnings | -$68M | -$77M | -$91M | -$177M | -$247M |
| Accumulated OCI | $4M | $6M | $11M | $32M | $0 |
| Total Stockholders Equity | $8M | $23M | $109M | $81M | $63M |
| Total Liabilities & Equity | $14M | $25M | $112M | $129M | $106M |
| — Key Metrics — | |||||
| Total Debt | $122K | $122K | $0 | $32M | $15M |
| Net Debt | -$7M | -$10M | -$79M | -$33M | -$22M |
| Total Investments | $62K | $63K | $0 | $0 | $0 |